title: ATRA-induced myositis in induction therapy of acute promyelocytic leukemia.
authors.affiliation: C/ General Oraá, 3-1, 28006- Madrid SPAIN. m-chamorro@navegalia.com
authors.forename: Carmen
authors.initials: C
authors.lastname: Martínez-Chamorro
authors.forename: Elena
authors.initials: E
authors.lastname: Martínez
authors.forename: Juan José
authors.initials: JJ
authors.lastname: Gil-Fernández
authors.forename: Aránzazu
authors.initials: A
authors.lastname: Alonso
authors.forename: Antonio
authors.initials: A
authors.lastname: Escudero
authors.forename: José Maria
authors.initials: JM
authors.lastname: Fernández-Rañada
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D009220:Myositis / Q000139:chemically induced* / Q000188:drug therapy; D016463:Sweet Syndrome / Q000139:chemically induced; D014212:Tretinoin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D014212:Tretinoin; D003907:Dexamethasone